US$3.87-2.4%9月29日 收盘
LENZ Therapeutics, Inc. 预定于 2026年11月4日发布下一份财报。日期来自 Nasdaq 财报日历,公司有时会调整。
截至 2026年6月30日 的季度,与去年同季度相比。
| 指标 | 截至该日的 3 个月2026年6月30日 | 截至该日的 3 个月2025年3月31日 | 变动 |
|---|---|---|---|
| 营业收入合计 | US$5.5M | US$0.00 | — |
| 利润 | -US$31.9M | -US$14.9M | -114.04% |
| 每股收益 | -US$1.02 | -US$0.53 | -92.45% |
| 自由现金流 | -US$38.7M | -US$11.7M | -229.66% |
这些是单季度数字,不是滚动一年——本站其他地方的数字覆盖十二个月,会大得多。季节性业务在两者之间摆动很大:ServiceNow 在十二月季度赚 20 亿美元自由现金流,在六月季度只有 5 亿。
对比对象是去年同一季度,而不是分析师预测。要说“超预期”或“不及预期”需要一致预期数据,那是我们没有的授权数据——而搞错它比不提更糟。
暂无 LENZ Therapeutics, Inc. 的业绩电话会文字记录。
“We are encouraged by the early refill behavior we are seeing with VIZZ. The majority of ePharmacy patients have purchased multiple monthly packs since launch, and among those patients, our Q4 2025 and Q1 2026 cohorts are tracking to average annualized utilization of five packs per patient. These trends reinforce the value VIZZ is delivering in the real world,”
逐字引自公告,且只在文件将其归于具名人士时才展示。
公告在收盘后或开盘前发布,因此这里的变动是随后的那个交易日。
Presbyopia is the inevitable loss of near vision associated with aging, impacting the daily lives of nearly all people over the age of 45. As people age, the crystalline lens in their eyes gradually hardens and becomes less able to change shape. This loss of elasticity reduces the lens’s ability to focus incoming light from near objects onto the retina. Adults over 50 years of age lose, on average, 1.5 lines of near vision every six years. Although the progression of presbyopia is gradual, presbyopes often experience an abrupt change in their daily life as the symptoms become more pronounced starting in their mid-40s, when reading glasses or other corrective aids are suddenly necessary to read text or conduct close-up work. Presbyopia is typically self-diagnosed and self-managed with over-the-counter reading glasses, or managed, after evaluation by an ECP, with prescription reading or bifocal glasses or multifocal
公司自己的描述,取自公告末尾。
引述和公司简介来自 LENZ Therapeutics, Inc. 于 2026年8月11日 提交的第 2.02 项 8-K 文件;表格根据其季度报告编制。 在 EDGAR 上阅读公告 股价已按拆股和分红复权。